Paul J. Nietert, PhD

Letter to the Editor

Dr. Brawman-Mintzer and Colleagues Reply to "Sedative Effects of Low-Dose Risperidone in GAD Patients and Risk of Drug Interactions"

August 1, 2006

Original Research

Adjunctive Risperidone in Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study

October 14, 2005